Please use this identifier to cite or link to this item:
https://doi.org/10.1124/jpet.110.165498
DC Field | Value | |
---|---|---|
dc.title | Identification of β-escin as a novel inhibitor of signal transducer and activator of transcription 3/janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells | |
dc.contributor.author | Tan, S.M.-L. | |
dc.contributor.author | Li, F. | |
dc.contributor.author | Rajendran, P. | |
dc.contributor.author | Kumar, A.P. | |
dc.contributor.author | Sethi, G. | |
dc.contributor.author | Hui, K.M. | |
dc.date.accessioned | 2011-09-29T06:42:51Z | |
dc.date.available | 2011-09-29T06:42:51Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | Tan, S.M.-L., Li, F., Rajendran, P., Kumar, A.P., Sethi, G., Hui, K.M. (2010). Identification of β-escin as a novel inhibitor of signal transducer and activator of transcription 3/janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. Journal of Pharmacology and Experimental Therapeutics 334 (1) : 285-293. ScholarBank@NUS Repository. https://doi.org/10.1124/jpet.110.165498 | |
dc.identifier.issn | 00223565 | |
dc.identifier.issn | 15210103 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/27403 | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1124/jpet.110.165498 | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | BIOLOGICAL SCIENCES | |
dc.contributor.department | PHARMACOLOGY | |
dc.description.doi | 10.1124/jpet.110.165498 | |
dc.description.sourcetitle | Journal of Pharmacology and Experimental Therapeutics | |
dc.description.volume | 334 | |
dc.description.issue | 1 | |
dc.description.page | 285-293 | |
dc.identifier.isiut | 000278901000032 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.